- Home
- IMNM vs TIPT Comparison
IMNM vs TIPT Comparison
Compare IMNM & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- TIPT
- Stock Information
- Founded
- IMNM 2006
- TIPT 2007
- Country
- IMNM United States
- TIPT United States
- Employees
- IMNM N/A
- TIPT N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- TIPT Property-Casualty Insurers
- Sector
- IMNM Health Care
- TIPT Finance
- Exchange
- IMNM Nasdaq
- TIPT Nasdaq
- Market Cap
- IMNM 987.1M
- TIPT 881.6M
- IPO Year
- IMNM 2020
- TIPT 2007
- Fundamental
- Price
- IMNM $13.83
- TIPT $18.27
- Analyst Decision
- IMNM Strong Buy
- TIPT
- Analyst Count
- IMNM 9
- TIPT 0
- Target Price
- IMNM $24.89
- TIPT N/A
- AVG Volume (30 Days)
- IMNM 2.0M
- TIPT 415.2K
- Earning Date
- IMNM 11-12-2025
- TIPT 10-29-2025
- Dividend Yield
- IMNM N/A
- TIPT 1.31%
- EPS Growth
- IMNM N/A
- TIPT 74.19
- EPS
- IMNM N/A
- TIPT 1.29
- Revenue
- IMNM $12,589,000.00
- TIPT $2,024,136,000.00
- Revenue This Year
- IMNM N/A
- TIPT N/A
- Revenue Next Year
- IMNM $154.70
- TIPT N/A
- P/E Ratio
- IMNM N/A
- TIPT $14.09
- Revenue Growth
- IMNM 16.74
- TIPT 6.10
- 52 Week Low
- IMNM $5.15
- TIPT $17.80
- 52 Week High
- IMNM $15.13
- TIPT $27.41
- Technical
- Relative Strength Index (RSI)
- IMNM 67.38
- TIPT 32.04
- Support Level
- IMNM $11.25
- TIPT $17.85
- Resistance Level
- IMNM $12.00
- TIPT $27.38
- Average True Range (ATR)
- IMNM 1.01
- TIPT 1.42
- MACD
- IMNM 0.40
- TIPT -0.49
- Stochastic Oscillator
- IMNM 87.06
- TIPT 4.28
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.